The United States cannabis industry represents a significant growth opportunity and we have been monitoring the companies that are levered to this burgeoning market. During the last year, there has been a significant increase in the number of states that have legalized some form of legal cannabis and we are favorable on this trend.
In 2018, several leading United States cannabis companies have commenced trading on the Canadian Stock Exchange (CSE) and we have been closely monitoring this trend. Today, we want to issue an update on a leading United States opportunity that has been flying under the radar.
The company, Liberty Health Sciences (LHS.CN) (LHSIF) has been laser focused on the medical cannabis opportunity in Florida and has been in the middle of a major expansion. The company is well positioned for growth and will be the largest medical cannabis producer in the state of Florida once its expansion is complete.
Liberty Health: A Top Pick for 2019
Although Liberty Health has been primarily focused on the opportunity in Florida, the company has had its finger on the pulse of the United States markets and has been focused on entering new cannabis markets. Last year, the company expanded into Ohio as well as Massachusetts and is planning to replicate the success it has had in Florida in these emerging cannabis markets.
Liberty Health Sciences has been nothing short of an execution story and we are bullish on the growth prospects going forward. The leverage the East Coast of the United States is significant, and the Florida medical cannabis market represents a massive opportunity since the company is allowed to open up to 30 dispensaries in the state. Currently, Liberty Health operates seven dispensaries and six delivery hubs in Florida. The company expects to open another seven dispensaries by the end of February for a total of 14 dispensaries across Florida, including locations in Miami, Boca Raton and Gainesville.
Liberty Health has been executing on the Ohio medical marijuana market and we are favorable on the growth prospects going forward. The company as well as its joint venture partner, the Schottenstein Group, expects to open their dispensary in Dayton, Ohio by the end of March. The companies have secured a 10,000 square foot processing facility, which will be used for extraction, refining, formulation and packaging. The processing facility is expected to open in the spring of 2019, and we expect this to prove to be a significant value driver for the company.
A Leading Cannabis Firm that is Trading at a Discount
One of the reason why we are favorable on Liberty Health is due to the management team and the valuation. When compared to its peers, Liberty Health is trading at a significant discount and we think this has created a great opportunity for investors. When it comes to the management team, Liberty Health is led by a team that is focused on creating value for shareholders.
During the last month, Liberty Health has rallied well off its lows and we think this company has significant room for growth. In December, negative reports were issued on Aphria (APHA.TO) (APHA) and this put considerable pressure on Liberty Health. The weakness was not based on fundamentals and it created a great opportunity for investors to invest in a high-quality cannabis company that has massive growth potential. Liberty Health has significant catalysts for growth and is well positioned to take market share in Florida while expanding into new market and this is an opportunity that cannot be missed.
Going forward, Liberty Health has significant growth prospects and this is a testament to the strength of the management team. To learn more about this leading United States cannabis company, please reach out to email@example.com.